X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (46) 46
index medicus (42) 42
male (38) 38
infectious diseases (37) 37
hiv (35) 35
female (32) 32
adult (27) 27
middle aged (27) 27
risk factors (25) 25
immunology (22) 22
hiv infections - drug therapy (21) 21
hiv infection (18) 18
hiv infections - complications (18) 18
human immunodeficiency virus--hiv (18) 18
610 medicine & health (16) 16
microbiology (15) 15
antiretroviral therapy (14) 14
cohort studies (14) 14
mortality (14) 14
clinic for infectious diseases (13) 13
health aspects (13) 13
infections (13) 13
hepatitis (12) 12
therapy (12) 12
switzerland (11) 11
switzerland - epidemiology (11) 11
care and treatment (10) 10
infection (10) 10
prospective studies (10) 10
virus diseases (10) 10
infected patients (9) 9
risk-factors (9) 9
viruses (9) 9
aged (8) 8
anti-hiv agents - therapeutic use (8) 8
antiretroviral drugs (8) 8
comorbidity (8) 8
epidemiology (8) 8
hiv infections - epidemiology (8) 8
hiv infections - virology (8) 8
human-immunodeficiency-virus (8) 8
research (8) 8
viral load (8) 8
coinfection (7) 7
drug therapy (7) 7
drug therapy, combination (7) 7
liver (7) 7
liver diseases (7) 7
risk (7) 7
abridged index medicus (6) 6
aids (6) 6
antiretroviral agents (6) 6
antiviral agents (6) 6
cd4 lymphocyte count (6) 6
cohort (6) 6
disease (6) 6
hiv patients (6) 6
hiv/aids (6) 6
prevalence (6) 6
progression (6) 6
adolescent (5) 5
aging (5) 5
antiretroviral therapy, highly active - adverse effects (5) 5
cardiovascular disease (5) 5
complications and side effects (5) 5
hepatitis c - epidemiology (5) 5
hepatitis c virus (5) 5
hiv-1 - genetics (5) 5
incidence (5) 5
major (5) 5
medical research (5) 5
men (5) 5
multidisciplinary sciences (5) 5
seroepidemiologic studies (5) 5
stroke (5) 5
substance abuse, intravenous - epidemiology (5) 5
usage (5) 5
young adult (5) 5
acquired immune deficiency syndrome--aids (4) 4
aids/hiv (4) 4
alanine aminotransferase (4) 4
anti-hiv agents - adverse effects (4) 4
anti-retroviral agents - adverse effects (4) 4
anti-retroviral agents - therapeutic use (4) 4
antiretrovirals (4) 4
article (4) 4
cd4 antigen (4) 4
chronic infection (4) 4
dosage and administration (4) 4
evolution (4) 4
fibrosis (4) 4
hepacivirus - genetics (4) 4
hepatitis c (4) 4
hepatotoxicity (4) 4
highly active antiretroviral therapy (4) 4
hiv infections - mortality (4) 4
homosexuality, male - statistics & numerical data (4) 4
impact (4) 4
medicine (4) 4
medicine, experimental (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 3/2013, Volume 56, Issue 6, pp. 870 - 879
Journal Article
Journal Article
EMERGING INFECTIOUS DISEASES, ISSN 1080-6040, 06/2011, Volume 17, Issue 6, pp. 1074 - 1078
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 7/2016, Volume 72, Issue 7, pp. 859 - 867
Some macrolide and quinolone antibiotics (MQABs) are associated with QT prolongation and life-threatening torsade de pointes (TdP) arrhythmia. MQAB may also... 
Pharmacoepidemiology | Torsade de pointes (TdP) | Biomedicine | Drug interactions | Macrolide and quinolone antibiotics | Pharmacology/Toxicology | Drug safety | ECG monitoring | MORTALITY | POPULATION | INTERVAL PROLONGATION | CARDIAC-ARRHYTHMIAS | RISK | OF-CARDIOLOGY FOUNDATION | AMERICAN-HEART-ASSOCIATION | SCIENTIFIC STATEMENT | TORSADE-DE-POINTES | PHARMACOLOGY & PHARMACY | CIPROFLOXACIN | Simvastatin - therapeutic use | Simvastatin - adverse effects | Humans | Middle Aged | Long QT Syndrome - chemically induced | Male | Young Adult | Anti-Bacterial Agents - therapeutic use | Drug Interactions | Quinolones - adverse effects | Quinolones - therapeutic use | Aged, 80 and over | Electrocardiography | Adult | Female | Anti-Bacterial Agents - adverse effects | Drug Therapy, Combination | Atorvastatin Calcium - adverse effects | Atorvastatin Calcium - therapeutic use | Medication Errors | Tertiary Care Centers | Risk Factors | Torsades de Pointes - chemically induced | Clonidine - adverse effects | Clonidine - therapeutic use | Clonidine - analogs & derivatives | Macrolides - adverse effects | Adolescent | Aged | Macrolides - therapeutic use | Safety and security measures | Arrhythmia | Isoenzymes | Electrocardiogram | Antibacterial agents | Heart rate | Patient safety | Side effects | Pharmacology | Antibiotics | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2012, Volume 109, Issue 8, pp. 3035 - 3040
Journal Article
Praxis, ISSN 1661-8157, 12/2014, Volume 103, Issue 25, pp. 1491 - 1498
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2/2010, Volume 50, Issue 4, pp. 502 - 511
Journal Article
NATURE COMMUNICATIONS, ISSN 2041-1723, 07/2019, Volume 10, Issue 1, pp. 3193 - 11
Journal Article
Journal Article
Journal Article
BMC INFECTIOUS DISEASES, ISSN 1471-2334, 10/2019, Volume 19, Issue 1, pp. 1 - 9
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, pp. e0133879 - e0133879
Background Ribavirin (RBV) is an essential component of most current hepatitis C (HCV) treatment regimens and still standard of care in the combination with... 
GENETIC-VARIATION | IL28B | VIRUS | MULTIDISCIPLINARY SCIENCES | CHRONIC HEPATITIS-C | ALPHA-2A PLUS RIBAVIRIN | INFECTED PATIENTS | PEGINTERFERON | Recombinant Proteins - therapeutic use | Prospective Studies | Follow-Up Studies | Coinfection - drug therapy | Humans | Middle Aged | Hepatitis C, Chronic - virology | Coinfection - blood | Male | Hepatitis C, Chronic - complications | Polyethylene Glycols - therapeutic use | Coinfection - complications | Adult | Female | Drug Therapy, Combination | HIV Infections - blood | Hepacivirus - drug effects | Ribavirin - blood | Antiviral Agents - therapeutic use | HIV-1 - drug effects | HIV Infections - virology | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Coinfection - virology | Hepatitis C, Chronic - blood | HIV Infections - complications | HIV Infections - drug therapy | Drug Monitoring | Infection | Medical research | Comorbidity | Analysis | Medicine, Experimental | Interferon | Research | Biological response modifiers | Hepatitis C virus | HIV (Viruses) | Hepatitis C | Health aspects | Laboratories | Antimicrobial agents | Infections | Pharmacology | Regression analysis | Patients | Epidemiology | Ribavirin | Hepatitis | Genotype & phenotype | Chemotherapy | Infectious diseases | Human immunodeficiency virus--HIV | Gastroenterology | Drug dosages | Genotypes | Index Medicus | HIV | Human immunodeficiency virus
Journal Article
Journal Article